健脾固肾化瘀方治疗糖尿病肾病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.2

基金项目:

河南省医学科技攻关计划项目(201708203)


Clinical Study on Jianpi Gushen Huayu Prescription for Diabetic Nephropathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察健脾固肾化瘀方治疗糖尿病肾病的临床疗效。方法:选取糖尿病肾病患者108 例,按随机数字表法分为观察组和对照组各54 例。对照组给予常规对症治疗,观察组在对照组基础上给予健脾固肾化瘀方治疗。比较2 组临床疗效,检测治疗前后24 h 尿微量白蛋白排泄率(UAER)、尿微量白蛋白(mAlb)、尿结缔组织生长因子(CTGF) 水平及血清血管生成素(Ang) 及其受体(Tie-2) 水平,统计治疗前后中医证候积分。结果:观察组总有效率为94.44%,对照组为79.63%,观察组高于对照组(P<0.05)。治疗前,2 组尿UAER、mAlb、CTGF 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组尿UAER、mAlb、CTGF 水平较治疗前降低,且观察组尿UAER、mAlb、CTGF 水平低于对照组,差异均有统计学意义(P<0.05)。治疗前,2 组血清Ang 及Tie-2 水平比较,差异无统计学意义(P>0.05)。治疗后,2 组血清Ang、Tie-2 水平较治疗前降低,且观察组血清Ang、Tie-2 水平低于对照组,差异均有统计学意义(P<0.05)。治疗前,2 组中医证候积分比较,差异无统计学意义(P>0.05)。治疗后,2 组中医证候积分较治疗前降低,且观察组中医证候积分低于对照组,差异均有统计学意义(P<0.05)。结论:健脾固肾化瘀方可降低糖尿病肾病患者尿UAER、mAlb、CTGF 水平和血清Ang 及其受体水平,改善临床症状,提高治疗效果。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Jianpi Gushen Huayu prescription for diabetic nephropathy. Methods:A total of 108 cases of patients with diabetic nephropathy were selected and divided into the observation group and the control group according to the random number table method,54 cases in each group. The control group was given routine symptomatic treatment, and the observation group was additionally given Jianpi Gushen Huayu prescription based on the treatment of the control group. The clinical effect was compared between the two groups. Before and after treatment,levels of 24- hour urinary micro- albumin excretion rate(UAER), urinary micro- albumin(mAlb), urinary connective tissue growth factor(CTGF),as well as angiogenin(Ang) and its receptor Tie2(Tie- 2) in serum were detected. Before and after treatment, Chinese medicine syndrome scores were counted. Results:The total effective rate was 94.44% in the observation group, higher than that of 79.63% in the control group(P<0.05). Before treatment, when compared levels of UAER, mAlb, and CTGF in urine between the two groups, there was no significance in the difference(P>0.05). After treatment, levels of UAER,mAlb,and CTGF in urine in the two groups were decreased when compared with those before treatment,and the three levels in the observation group were lower than those in the control group, differences being significant(P<0.05). Before treatment,when compared levels of Ang and Tie-2 in serum between the two groups,there was no significance in the difference(P>0.05). After treatment, levels of Ang and Tie- 2 in serum in the two groups were decreased when compared with those before treatment, and the two levels in the observation group were lower than those in the control group, differences being significant(P<0.05). Before treatment, when compared Chinese medicine syndrome scores between the two groups,there was no significance in the difference(P>0.05). After treatment,Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment,and the scores in the observation group were lower than those in the control group, differences being significant(P<0.05). Conclusion: For patients with diabetic nephropathy,Jianpi Gushen Huayu prescription can reduce levels of UAER,mAlb,CTGF,as well as Ang and its receptor in serum,relieve clinical symptoms,and improve clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

鲁阳侠,孟帆,杨芳,周云蕾.健脾固肾化瘀方治疗糖尿病肾病临床研究[J].新中医,2021,53(3):77-80

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-02-03
  • 出版日期:
文章二维码